Nalaganje...
Therapeutic management options for stage III non-small cell lung cancer
Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered locally advanced at the time of diagnosis. Patients with locally advanced stage III NSCLC consists of a heterogeneous popula...
Shranjeno v:
| izdano v: | World J Clin Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5309711/ https://ncbi.nlm.nih.gov/pubmed/28246582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v8.i1.1 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|